You Have Got a Fast CAR: Chimeric Antigen Receptor NK Cells in Cancer Therapy

The clinical success stories of chimeric antigen receptor (CAR)-T cell therapy against B-cell malignancies have contributed to immunotherapy being at the forefront of cancer therapy today. Their success has fueled interest in improving CAR constructs, identifying additional antigens to target, and c...

Descripción completa

Detalles Bibliográficos
Autores principales: Pfefferle, Aline, Huntington, Nicholas D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140022/
https://www.ncbi.nlm.nih.gov/pubmed/32192067
http://dx.doi.org/10.3390/cancers12030706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140022/
https://www.ncbi.nlm.nih.gov/pubmed/32192067
http://dx.doi.org/10.3390/cancers12030706

Ejemplares similares